⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
NVO
IONS
PFE
REGN
LXRX
VRTX
LLY
Diabetic Neuropathy Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
NVO
IONS
PFE
REGN
LXRX
VRTX
LLY
COLL
Single-Use Bioprocessing Market Projected to Reach US$ 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica
globenewswire.com
TMO
AMGN
PFE
BMY
GILD
REGN
AZN
LLY
MRK
GSK
Global Oncology Clinical Trials Market Projected to Reach US$ 25.61 Billion by 2035, Supported by Advances in Precision and Targeted Therapies Says Astute Analytica
globenewswire.com
MAR
LLY
Scribe Therapeutics Projected to Enter the Clinic in Mid-2026 with STX-1150, a PCSK9-targeting CRISPR Epigenetic Silencing Therapy for Durable LDL-C Reduction
businesswire.com
LLY
SNY
Lilly's sofetabart mipitecan receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer
prnewswire.com
LLY
Shed GLP-1 Weight Loss Review 2026: Examining the Telehealth Platform's Process, Pricing, and Medication Options
accessnewswire.com
NVS
LLY
Italy on the Move Brings 200+ Italy-US Biotech, Pharma and Investment Leaders Together in San Francisco During JPM Week
prnewswire.com
GOSS
LLY
$576.5 Million Fetal Alcohol Spectrum Disorder Treatment Market - Global Forecast 2026-2032
globenewswire.com
LLY
JNJ
PFE
NVS
SNY
Refills GLP-1 Weight Loss Guide 2026: Branded vs Compounded Options, Eligibility, Pricing Factors, and FDA Safety Notes
accessnewswire.com
NVO
LLY